Full Text
Full text is available in PDF
Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Effect of Ribavirin Therapy on Salivary Gland Function: An Oral Medicine Prespective
Authors
11) Department of Oral & Maxillofacial Surgery, Faculty of Dentistry, Tehran University of Medical Sciences, Tehran, IR Iran.2) Students Scientific Research Center, Tehran University of Medical Sciences, nima.mahboobi@gmail.com, IR Iran
2Department of Gastroenterology and Liver Diseases, Faculty of Medicine, Tehran University of Medical Sciences, IR Iran
*Corresponding Author: 1) Department of Oral & Maxillofacial Surgery, Faculty of Dentistry, Tehran University of Medical Sciences, Tehran, IR Iran.2) Students Scientific Research Center, Tehran University of Medical Sciences, nima.mahboobi@gmail.com, IR Iran. Tel: +98-2166913292. Fax: +98-2166 495948. Email: nima.mahboobi@gmail.com
Published online:Nov 30, 2011
Article type:Letter
Received:Sep 17, 2011
Accepted:Oct 16, 2011
How to Cite:Mahboobi N, Haghighi Z. Effect of Ribavirin Therapy on Salivary Gland Function: An Oral Medicine Prespective. Hepat Mon. 2011;11(11):. doi: https://doi.org/10.5812/kowsar.1735143X.786
Abstract
Please cite this paper as:
Mahboobi N, Haghigh Z. Effect of Ribavirin Therapy on Salivary Gland Function: An Oral Medicine Prespective. Hepat Mon.
2011;11(11):925-6.DOI: 10.5812/kowsar.1735143X.786
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
28
Feb
2013
Commentary on: The optimal Dose of Ribavirin for Chronic Hepatitis C: From Literature Evidence to Clinical Practice
Mortada El-Shabrawi,
Mona Isa
El-Shabrawi M, Isa M. Commentary on: The optimal Dose of Ribavirin for Chronic Hepatitis C: From Literature Evidence to Clinical Practice. Hepat Mon. 2013;13(2):e7867. doi: https://doi.org/10.5812/hepatmon.7867
31
Mar
2011
Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B
Chen Dong,
Xing Dai,
Jiuhong Liang,
Min Dong,
Jihong Meng
Dong C, Dai X, Liang J, Dong M, Meng J. Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B. Hepat Mon. 2012;12(6):. doi: https://doi.org/10.5812/hepatmon.6194
31
Mar
2011
Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B
Amir Mostaghni,
Alireza Soltanian,
Elaheh Mokhtari,
Sara Japoni,
Davood Mehrabani
Mostaghni A, Soltanian A, Mokhtari E, Japoni S, Mehrabani D. Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B. Hepat Mon. 2011;11(3):. doi:
31
Mar
2011
Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B
Grazyna Kowalczyk-Ziomek,
Eugeniusz Czecior,
Grzegorz Wyrobiec,
Marzena Harabin-Slowinska,
Malgorzata Juszko-Piekut,
Bogumila Braczkowska
,et al.Kowalczyk-Ziomek G, Czecior E, Wyrobiec G, Harabin-Slowinska M, Juszko-Piekut M, et al. Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B. Hepat Mon. 2011;11(6):. doi:
31
Mar
2011
Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B
Mostafa Alavi-Moghaddam
Alavi-Moghaddam M. Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B. Hepat Mon. 2011;11(3):. doi:
Cited by
- Scopus by DOI: 2
Last Update: 2 weeks ago
- Scopus by Title: 2
Last Update: 2 weeks ago
- Scopus by Title (Ref): 2
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 8 hours ago
- OpenAlex: 1
Last Update: 13 hours ago
- OpenCitations: 0
Last Update: 4 days ago
Comments
Number of Comments:0